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1. Introduction
The possibility has arisen within the last three decades that major diseases that directly af‐
fect humankind worldwide may be preventable by the simple improving the dietary intake
of those nutrient substances that have become called “antioxidant nutrients”.
There is no doubt that successful prevention is the key to controlling morbidity and mortali‐
ty from chronic diseases affecting humankind. Prevention provides: the methods to avoid
occurrence of disease and most population-based health promotion efforts are of this type;
methods to diagnose and treat extant disease in early stages before it causes significant mor‐
bidity; methods to reduce negative impact of extant disease by restoring function and reduc‐
ing disease-related complications; and finally, the methods to mitigate or avoid results of
unnecessary or excessive interventions in the health system.
The quality and quantity of diet with respect to the intake of fresh food (fruits, seeds and
vegetables) may improve our health and consequently decrease the risk of any disease. Cur‐
rently, the antioxidant nutrients are the vitamins C and E and β-carotene. However, it is
worthy to mention that these compounds are involved in other functions a part from being
antioxidant nutrients.
Selenium (Se), a trace mineral. Is the 34th element and is located between sulfur and telluri‐
um in Group 16 in the periodic table. It is a nonmetallic element and its properties are inter‐
mediate between adjacent sulfur and tellurium. It was originally discovered by a German
chemist Martin Heinric Klaproth, but misidentified as tellurium. Later, in 1818 a Swedish
chemist Jons Jacob Berzelius discovered selenium and was named after the Greek goddess
of the moon, Selene [1] and its name was associated with tellurium, a name for earth. He
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observed the element as a deposit following the oxidation of sulfur dioxide from cooper pyr‐
ites. It ranks seventieth in abundance among the elements and is distributed in the Earth’s
crust at concentrations averaging 0.09 mg/kg [2]. Selenium has six major stable isotopes
have been reported and the most abundant in nature are 80Se (49.6%) and 78Se (23.8%) [3].
In general, selenium is present in the environment in elemental form or in the form of sele‐
nide (Se2-), selenate (SeO42-), or selenite (SeO32-). The identity and amounts of the various oxi‐
dation-state species in soils depends enormously on the redox-potential conditions. The
lower oxidation states predominate in anaerobic conditions, acidic soils, and the higher oxi‐
dation states are favored in alkaline and aerobic conditions. Both selenites and selenates are
taken up by plants and converted to protein-bound selenocysteine and selenomethionine,
soluble inorganic forms, several free amino acids, and volatile organoselenium compounds.
The elemental form of selenium, selenium dioxide, and volatile organoselenium compounds
produced by industries and plants are incorporated in the environment. Selenium occurs
naturally in water in trace amounts as a result of geochemical processes, such as weathering
of rocks and erosion of soils, and is usually present in water as selenate or selenite; however
the elemental form may be carried in suspension [4].
Interest in selenium and health was focused primarily on the potentially toxic effects of high
intakes in humans, stimulated by reports of alkali disease in livestock raised in seleniferous
areas, in the last century [5]. Selenium is a trace mineral that is essential to good health but
required only small amounts [6,7]. Selenium is considered as essential human micronutrient
and is incorporated into proteins to make selenoproteins. Selenium is present in the seleno‐
proteins, as the aminoacid selenocysteine (Se-Cys) [8-12].
Dietary levels of the desired amount of Se are in a very narrow range: consumption of foods
containing less than 0.1 mg kg-1 of this element will result in Se deficiency, whereas dietary
levels above 1 mg kg-1 will lead to toxic manifestations [13]. Se status varies significantly
across different populations and different ethnic groups [14-15].
Selenium enters the food chain through plants, and the amount and bioavailability of seleni‐
um in the soil typically reflects the plant level. Selenium is provided by the diet in humans,
but may also be provided from drinking water, environmental pollution, and in recent years
through supplementation [16,17]. Plants convert Se mainly into selenomethionine (Se-Met)
and incorporated it into protein place of methionine. More than 50% of the total Se content
of the plant exist as Se-Met, the rest exist as selenocysteine (Se-Cys), methyl-Se-Cys and c-
glutamyl-Se-methyl-Cys. The later compounds are not significantly incorporated into plant
protein. Higher animals are unable to synthesize Se-Met and only Se-Cys was detected in
rats supplemented with Se as selenite [18]. Animals that eat grains (Brazil nuts, sunflower
seeds, walnuts and grains) that were grown in selenium rich soil have higher levels of sele‐
nium in their muscles, liver, kidney, heart, spleen and fingernails. Other natural selenium
sources are butter, eggs, brewer’s yeast, wheat germ, garlic, raspberry leaf, radish, horserad‐
ish, onions, shellfish, broccoli, fennel seed and ginseng, among other sources.
Most ingested forms of selenium ultimately are metabolized to low molecular weight inor‐
ganic and organic compounds that play a central role in human health either via incorpora‐
tion into selenoproteins or binding to selenium binding proteins [19]. Therefore, a
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tremendous effort has been directed toward the synthesis of stable organoselenium com‐
pounds that could be used as antioxidants, enzyme modulators, antitumor, antimicrobials,
antihypertensive agents, antivirals and cytokine inducers. Several excellent books and re‐
views appeared in literature describing the biological function of organoselenium com‐
pounds [20-22].
The role of organoselenium compounds as antioxidants, as enzyme modulators, photo-chy‐
motherapeutic agents, cytokine inducers and immunomodulators, and antihypertensive and
cardiotonic agents have been recently described in literature [23].
The essentiality of selenium results as a necessary component of the active center of a num‐
ber of selenoenzymes. Selenium functions as a redox center. The term selenoprotein is any
protein that includes in its primary sequence of amino acids, the selenocysteine (Se-Cys) res‐
idue [24]. There are at least 30 selenoproteins that have been identified in mammals, and it
has been estimated that humans have about 25 selenoproteins, including glutathione peroxi‐
dase, thioredoxin reductase, iodothyronine, deiodinase, and selenoproteins P, W, and R
[25-27]. GPx accounts for 10–30% of plasma selenium, and selenoprotein P accounts for an‐
other 50% [28]. These enzymes protect cells from free radical damage and regulate DNA
transcription and cell proliferation. The glutathione and thioredoxin systems in particular
have long been considered the major pathways through which selenium exerts its potential
chemopreventive effect [24], while some investigations have also suggested growth inhibito‐
ry, proapoptotic activity for selenometabolites in premalignant cells [29]. Selenium is also in‐
volved in thyroid function, T cell immunity, and spermatogenesis [28], and is a competitive
antagonist of potentially carcinogenic heavy metals such as arsenic and cadmium [30].
The organism has several biological defense mechanisms against intracellular oxidative
stress such as superoxide dismutase, catalase, glutathione peroxidase and nonenzymatic an‐
tioxidants such as glutathione, vitamins A, C and E, riboflavin, a B vitamin and selenium
can also contribute to overcome oxidative stress [31].
Vitamin E is a fat-soluble vitamin known for its antioxidant capacity that is why it is well
known as a lipophilic antioxidant that protects membranes from being oxidatively damaged
as an electron donor to free radicals [32]. Vitamin E belongs to a group of the eight naturally
occurring vitamer forms, four tocopherols (α, β, γ, δ) and four tocotrienols (α, β, γ, δ) based
on the hydroxyl and methyl substitution in their phenolic rings, all of which have saturated
and three double bonds in their phytyl tails. α-tocopherol (from the Greek tokos = child,
phero = to bear and ol indicating that the substance is an alcohol, is the most abundant form
in nature; it’s the most active and corrects human E deficiency symptoms [33]. The most
abundant sources of vitamin E are vegetable oils, which typically contain all four tocopherol
(α, β, γ, δ) in varying proportions, Other important source are nuts and seeds such as sun‐
flower and amaranth seeds.
It is well known that all forms of vitamin E are lipid soluble they easily absorbed from the
intestinal lumen after dietary intake via micelles created by biliary and pancreatic secretions
[34-35]. Vitamin E is then incorporated into chylomicrons and secreted into the circulation
where, transported by various lipoproteins, it travels to the liver [36]. Plasma α-tocopherol
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concentrations in humans range from 11 to 37 μmol/L, whereas γ-tocopherol are between 2
and 5 μmol/L. The liver plays a central role in regulating α-tocopherol levels by directly act‐
ing on the distribution, metabolism, and excretion of this vitamin [37]. The major hepatic
regulatory mechanism is the α-tocopherol transfer protein, α-TTP, which has been identified
in a variety of mammals, including humans [38]. This protein facilitates secretion of α-toco‐
pherol from the liver into the bloodstream, by acquiring it from endosomes and then deliv‐
ering it to the plasma membrane where it is released and promptly associates with the
different nascent lipoproteins [39]. Plasma concentration of vitamin E depends completely
on the absorption, tissue delivery, and excretion rate. The estimated α-tocopherol half-life in
plasma of healthy individuals is ~ 48 to 60 H, which is much longer than the half-life of γ-
tocopherol approximately 15 H. These kinetic data underscore an interesting concept that
while α-tocopherol levels are maintained, the other forms of vitamin E are removed much
more rapidly [40].
2. Selenium and Health
Selenium deficiency is associated with the pathogenesis of wide variety of processes that af‐
fects our health and disease including the antioxidant activity, depression, allergies, pre‐
venting oxidative stress, HIV infection, in the brain, thyroid metabolism, cancer, diabetes
mellitus, male fertility, asthma, cardiovascular disorders, rheumatoid arthritis, pre-eclamp‐
sia, in immune function, in alleviate bone impairments, aging, gastrointestinal problems, se‐
lenium interactions and toxicity, anti-inflammatory effects, and hypertension. The list of
clinical disorders expected to be influenced by Se deficiency is rapidly growing with time.
Some selected issues regarding the role of Se in health and disease have been briefly out‐
lined as follows:
2.1. Se and antioxidant activity
Selenocysteine is recognized as the 21st amino acid, and it forms a predominant residue of
selenoproteins and selenoenzymes in biological tissues. The molecular structure of seleno‐
cystiene is an analogue of cysteine where a sulphur atom is replaced by Se. Even though Se
and sulphur share some similar chemical properties, there are also some differences. The R-
SeH with a pKa 5.2 is more is more acidic than R-SH with a pKa 8.5, and readily dissociated
at physiological pH, which may contribute to its biological reactivity. In the body, both or‐
ganic [selenocysteine(SeCys) and selenomethionine (SeMet)] and inorganic (selenite, selen‐
ate) Se compounds are readily metabolized to various forms of Se metabolites [41]. Of
particular importance during this metabolic process is the formation of hydrogen selenide
(H2Se) from selenite after the action of glutathione-coupled reactions via selenodiglutathione
(GS-Se-SG) and glutathione selenopersulfide (GS-SeH). H2Se is further metabolized and in‐
volved in the formation of methylselenol and dimethylselenide, which are exhaled or secret‐
ed via the skin. Selenium is also excreted in urine as trimethylselenonium ion and
selenosugar compounds [42]. The selenoproteins are classified on the basis of their biologi‐
cal function [25]. The first identified selenoprotein was glutathione peroxidase 1 (GPx1). The
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selenoenzymes with strong antioxidant activity are GPx, GPx1, GPx3, GPx4, GPx5 and
GPx6. In Humans GPx1 through GPx4 and GPx6 are selenocysteine containing enzymes.
These GPx play a significant role in protecting cells against oxidative damage from reactive
oxygen species (ROS) and reactive nitrogen species (RNS), which include superoxide, hy‐
drogen peroxide, hydroxyl radicals, nitric oxide and peroxynitrite [43-44]. The other essen‐
tial antioxidant selenoenzymes are the thioredoxin reductase (TrxR) where they use
thioredoxin (Trx) as a substrate to maintain a Trx/TrxR system in a reduced state for remov‐
al of harmful hydrogen peroxide and there are three types of TrxR. Iodothyronine deiodi‐
nase (DIO) have three subtypes, DIO 1, 2, and 3 [45].
2.2. Se and depression
In [46] selenium’s function as an antioxidant, and as a constituent of selenoproteins that are
important in redox homeostasis, warrants further investigation as a risk factor for depres‐
sion, and suggest a potentially novel modifiable factor in the primary prevention and man‐
agement of depression. Depression is becoming recognized as an inflammatory disorder,
accompanied by an accumulation of highly reactive oxygen species that overwhelm usual
defensive physiological processes [47-51]. Several indicators support a role for selenium in
normal brain function. During times of selenium deficiency, there is preferential storage of
selenium in the brain [52]. Selenium has significant modulatory effects on dopamine [53]
and dopamine plays a role in the pathophysiology of depression and other psychiatric ill‐
nesses [54]. Diminished levels of selenium in the brain are associated with cognitive decline
[55] and Alzheimer’s disease [56]. Selenium supplementation has been linked with improve‐
ments in mood [57] and protection against postpartum depression [58]. What is unclear is if
low dietary selenium is a risk factor for the development of depression. In recognition of se‐
lenium’s biological activity, it has been hypothesized that low levels of dietary selenium
would be associated with an increased risk of major depressive disorder (MDD) in a repre‐
sentative population-based sample of women.
Alterations in redox biology are established in depression; however, there are no prospec‐
tive epidemiological data on redox-active selenium in depression. It is known that seleni‐
um’s function as an antioxidant, and as a constituent of selenoproteins that are important in
redox homeostasis, warrants further investigation as a risk factor for depression, and sug‐
gest a potentially novel modifiable factor in the primary prevention and management of de‐
pression.
2.3. Selenium and allergies
The International Study of Asthma and Allergies in Childhood (ISAAC) found that one in
four New Zealand children aged 6–7 years had experienced asthma symptoms, which
placed New Zealand in the top four countries for asthma prevalence [59]. The reasons for
the high prevalence and severity of this condition or the increased prevalence of asthma
over the last 20 years are not well understood. One of a number of environmental factors
that have been proposed as a reason for the escalation in asthma prevalence is a decreasing
intake of dietary antioxidants [60]. It is well known that selenium is essential for the optimal
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functioning of the selenoenzymes glutathione peroxidases (GPx) and thioredoxin reductas‐
es, powerful antioxidants, and is found abundantly in lung tissue and the extracellular fluid
of the respiratory system [61]. Selenium has been implicated in inflammation by reducing
the severity of the inflammatory response through modulation of the pro-inflammatory leu‐
kotrienes, important mediators of acute asthmatic reactions as well as sustaining the inflam‐
matory process causing a late allergic reaction metabolism [62]. Evidence from randomized
controlled trials [63] and basic mechanistic work investigating the effect of selenium on
markers of inflammation and oxidative stress [62]. Evidences have supported a protective
role for selenium in asthma, although other studies have not [64-66]. The ISAAC study does
not support a strong association between selenium status and the high incidence of asthma
in New Zealand. However, there was a modest association between lower plasma selenium
and whole blood glutathione peroxidase activity and higher incidence of persistent wheeze
[67].
2.4. Selenium in preventing oxidative stress
The reactivity of organoselenium compounds [22,68] characterized by high nucleophilicity
and antioxidant potential, and provides the basis for their pharmacological activities in
mammalian models. Organochalcogens have been widely studied given their antioxidant
activity, which confers neuroprotection, antiulcer, and antidiabetic properties. Given the
complexity of mammalian models, understanding the cellular and molecular effects of orga‐
nochalcogens has been hampered. In reference [69] the nematode worm Caenorhabditis ele‐
gans is an alternative experimental model that affords easy genetic manipulations, green
fluorescent protein tagging, and in vivo live analysis of toxicity. Manganese (Mn)-exposed
worms exhibit oxidative-stress-induced neurodegeneration and life-span reduction. Dieth‐
yl-2-phenyl-2-tellurophenyl vinyl phosphonate (DPTVP) and 2-Phenyl-1,2-benzoisoselena‐
zol-3-(2H)-one (Ebselen) were tested for reversing the Mn-induced reduction in survival and
lifespan in this nematode. DPTVP was the most efficacious compound as compared to Ebse‐
len in reversing the Mn-induced toxicity and increasing in survival and life span. DPTVP
and ebselen act as antiaging agents in a model of Mn-induced toxicity and aging by regulat‐
ing DAF-16/FOXO signaling and attenuating oxidative stress.
Bone is a specialized connective tissue, which forms the framework of the body. Various
physiological conditions can adversely affect femoral bone metabolism. These physiological
conditions could be food deprivation [70], and iodine and/or selenium (Se) deficiency [71,72]
and antithyroid drugs [73] affects bone maturation. Selenium is an important protective ele‐
ment that may be used as a dietary supplement protecting against oxidative stress, cellular
damage and bone impairments [74].
2.5. Selenium in HIV infection
The HIV pandemic has placed a great demand upon the scientific community to develop ef‐
fective prevention and treatment methods. Since the beginning of the pandemic in 1981,
over 25 million people are estimated to have died from the disease [75]. It is currently a lead‐
ing cause of death in many parts of the world, and a disease that disproportionately affects
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the marginalized and socially disadvantaged. It is currently a leading cause of death in
many parts of the world, and a disease that disproportionately affects the marginalized and
socially disadvantaged. Many of those affected also suffer from chronic food insecurity and
malnutrition, so therapies that could potentially target both HIV disease and malnutrition,
such as multivitamins, have been extensively researched for potential benefits [76]. Among
such therapies, the antioxidant micronutrients theorized to have potential benefits in HIV
disease, apart from correcting deficiencies, have been examined frequently [77,78].
Selenium has an inhibitory effect on HIV in vitro through antioxidant effects of glutathione
peroxidase and other selenoproteins. Numerous studies have reported low selenium status
in HIV-infected individuals, and serum selenium concentration declines with disease pro‐
gression. Some cohort studies have shown an association between selenium deficiency and
progression to AIDS or mortality. In several randomized controlled trials, selenium supple‐
mentation has reduced hospitalizations and diarrheal morbidity, and improved CD4+ cell
counts, but the evidence remains mixed. Additional trials are recommended to study the ef‐
fect of selenium supplementation on opportunistic infections, and other HIV disease-related
comorbidities in the context of highly active antiretroviral therapy in both developing and
developed countries [79].
There is a historical record showing that organoselenium compounds can be used as antivi‐
ral and antibacterial agents. This topic has been reviewed by [22,23].
2.6. Selenium in the brain
In addition to the well-documented functions of Se as an antioxidant and in the regulation
of the thyroid and immune function [80]. Recent advances have indicated a role of Se in the
maintenance of brain function [81]. Selenium is widely distributed throughout the body, but
is particularly well maintained in the brain, even upon prolonged dietary Se deficiency [82].
In the brain, the highest concentration of Se is found in the gray matter, an area responsible
for chemical synaptic communication [83]. It has been shown that rats on a Se-deficient diet
for thirteen weeks retained Se in their brain, while their plasma Se concentrations were de‐
pleted [84]. After intraperitoneal injection of 75SeO32- into Se-deficient rats, the brain rapidly
sequesters a large portion of the available Se [85]. In the brain, it was found that the cerebel‐
lum accumulated the highest concentration of Se, followed by the cortex, medulla oblonga‐
ta, cerebral hemisphere, and the spinal cord. Interestingly, Se retention in the brain depends
on Selenoprotein P expression [86]. Because the body preferentially allocates available Se to
the brain during Se deficiency, Se may play an essential role in the brain. More evidence for
the brain being at the apex of Se retention is provided by a study showing that a six genera‐
tion Se deficiency in rats caused a more than 99% reduction of Se concentration in the liver,
blood, skeletal tissue, and muscle, while the brain retained a 60% of the Se [87]. Se concen‐
tration in Alzheimer’s brains was found to be 60% of the age-matched control individuals
[88]. Accumulated lines of evidence indicate important roles of selenoproteins in the mainte‐
nance of optimal brain functions via redox regulation. Decreased expression of several sele‐
noproteins is associated with the pathologies of a few age-associated neurodisorders,
including Parkinson’s disease, Alzheimer’s disease and epilepsy [81].
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Oxidative stress and generation of reactive oxygen species are strongly implicated in a num‐
ber of neuronal and neuromuscular disorders, including epilepsy. The functions of selenium
as an antioxidant trace element are believed to be carried out by selenoproteins that possess
antioxidant activities and the ability to promote neuronal cell survival [89]. It is known the
role of selenium in a detoxifying enzyme, glutathione peroxidase, this element has been
demonstrated to have a positive biological function in various aspects of human health [90].
Oxidative stress and generation of reactive oxygen species are strongly implicated in a num‐
ber of neurologic disorders including seizure disorders. Oxidative phosphorylation occur‐
ring in the mitochondria produces oxygen radicals routinely in all tissues as well as the
nervous system. One important defense may be to remove the oxygen radicals. Selenium-
requiring processes are involved in normal maintenance of cell function. However, when
the system is overused or chronically activated beyond its normal state, such as recurrent or
intractable seizures, abnormal increases in by-products can produce neuronal cell damage.
Selenium provides protection from reactive oxygen species–induced cell damage. The pro‐
posed mechanisms are mainly through the functions of seleno-dependent enzymes and sele‐
noproteins [82,91]. It seems that selenium plays an important role in stopping the vicious
cycle of oxidative stress and neuronal damage in patients with intractable seizures by restor‐
ing the defense mechanism.
2.7. Selenium and the thyroid
Some selenoproteins of the human selenoproteome display multiple genes performing simi‐
lar functions. The main selenoprotein families are the glutathione peroxidases (GPxs; seven
genes), the thioredoxin reductases (TRxs; three genes) and the iodothyronine deiodinases
(DIs; three genes) [92,93]. The GPxs, which possess oxidoreductase functions, protect the cell
from oxidative stress. The TRxs form a cellular redox system, existing in many organisms,
which is essential for cell development and proliferation. The DIs that catalyzes the conver‐
sion of T4 to T3 provides the sources of T3 production. It may thus be hypothesized that the
essential micronutrient selenium, in the form of Se-Cys, modulates redox-sensitive signaling
pathways and thereby potentially modifies selenoprotein gene expression. These findings
have aroused growing interest of the scientific community in this multifaceted element. In
this context, whereas selenium administration for cancer chemoprevention produced ques‐
tionable results, those of selenium supplementation in patients with autoimmune thyroid
disease have been more encouraging. In [94] comprises an in-depth discussion of the link
between selenium and thyroid function; it provides a critical analysis of the data contained
in recent studies, an update and evaluation of current knowledge with regard to the mecha‐
nisms of action of selenium, and reflections on the prospects for selenium supplementation
in thyroid pathology.
Evidence in support of selenium supplementation in thyroid autoimmune disease is evalu‐
ated; the results herein presented demonstrating the potential effectiveness of selenium in
reducing the antithyroid peroxidase titer and improving the echostructure in the ultrasound
examination. However, considerable discord remains as to who should comprise target
groups for selenium treatment, who will most benefit from such treatment, the precise im‐
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pact of the basal antithyroid peroxidase level, and the effect of disease duration on the treat‐
ment outcome. Clearly, further in-depth studies and evaluation are required concerning the
mechanism of action of selenium as well as the choice of supplements or dietary intake.
2.8. Selenium in cancer
The reactive oxygen species (ROS) are derived from cellular oxygen metabolism and from
exogenous sources. An excess of ROS results in oxidative stress and may eventually cause
cell death. ROS levels within cells and in extracellular body fluids are controlled by concert‐
ed action of enzymatic and non-enzymatic antioxidants. The essential trace element seleni‐
um exerts its antioxidant function mainly in the form of selenocysteine residues as an
integral constituent of ROS-detoxifying selenoenzymes such as glutathione peroxidases
(GPx), thioredoxin reductases (TrxR) and possibly selenoprotein P (SeP). In particular, the
dual role of selenoprotein P as selenium transporter and antioxidant enzyme is highlighted
herein. A cytoprotective effect of selenium supplementation has been demonstrated for vari‐
ous cell types including neurons and astrocytes as well as endothelial cells. Maintenance of
full GPx and TrxR activity by adequate dietary selenium supply has been proposed to be
useful for the prevention of several cardiovascular and neurological disorders. On the other
hand, selenium supplementation at supranutritional levels has been utilized for cancer pre‐
vention: antioxidant selenoenzymes as well as prooxidant effects of selenocompounds on tu‐
mor cells are thought to be involved in the anti-carcinogenic action of selenium [95,96].
Among various antioxidant minerals, selenium it may prove to be of major significance as a
prophylactic agent against cancer. Low blood selenium concentration and incidence of carci‐
nogenesis have been well observed in both animals [97] as well as in human studies [98]. In
addition, it has been demonstrated in a double blind randomized cancer prevention trial in
humans that increased selenium intake has a significant role in the treatment of cancer [99].
A similar prospective study could also be designed for other cancers to determine the che‐
mopreventive effect of Se. Selenium has also been reported to have a beneficial effect on the
incidence of gastrointestinal and bladder cancers [100,101].
Although selenium is reported to play a significant role in cancer development, its exact an‐
ticancer mechanism of action at molecular levels is not fully understood. However, it has
been hypothesized that the most possible mechanistic action of Se as chemoprevention is its
role in the antioxidant defense systems to reduce oxidative stress and limit DNA damage
[24,102]. Experiments carried out within the framework of a canine model using male beagle
dogs to mimic prostate cancer in humans showed that the damage to DNA was significantly
reduced when the animals were exposed to increased Se dietary supplements [103]. The ef‐
fectiveness of Se in the prevention of DNA damage, however, depends on its chemical
forms. In an in vitro study [104] found that selenocysteine inhibited DNA damage more
strongly than the selenomethionine. Other possible anticancer mechanisms of Se include the
induction of apoptosis, cell-cycle arrest and DNA-repair genes, inhibition of protein kinase
C activity and cell growth and effect on estrogen- and androgen-receptor expression [102].
In [105] knowledge of the plasma selenium levels are associated with optimized concentra‐
tion or activity of specific selenoproteins can provide considerable insights from epidemio‐
Emerging Role of Natural Antioxidants in Chronic Disease Prevention with an Emphasis on Vitamin E and Selenium
http://dx.doi.org/10.5772/51610
427
logical data on the possible involvement of those selenoproteins in health, most notably
with respect to cancer. For cohort studies, if selenoproteins such as glutathione peroxidase
and selenoprotein P are relevant to cancer, one might only expect to see an effect on risk
when the concentrations in the cohort range from below, to above, the level needed to opti‐
mize the activity or concentration of these enzymes. Similarly, trials would only show a ben‐
eficial effect of supplementation if selenium status were raised from below, to above, the
optimal concentration for the selenoproteins likely to be implicated in cancer risk, as occur‐
red in the Nutritional Prevention of Cancer (NPC) trial but not in Selenium and Vitamin E
Cancer Prevention Trial (SELECT). The most powerful evidence for the involvement of sele‐
noproteins in human health comes from epidemiological studies that have related single nu‐
cleotide polymorphisms in selenoproteins to disease risk. The totality of the evidence
currently implicates GPx1, GPx4, SEPS1, Sep15, SEPP1 and TXNRD1 in conditions such as
cardiovascular disease, pre-eclampsia and cancer. Future studies therefore need to deter‐
mine not only selenium status, but genotype, both in selenoproteins and related pathways,
when investigating the relationship of selenium with disease risk.
2.9. Selenium in diabetes
The evidence supporting an effect of selenium on the risk of diabetes is variable, occasional‐
ly conflicting, and limited to very few human studies. Following a trial investigating the ef‐
fect of selenium supplementation (200 μg/day) on skin cancer, subsequent analysis showed
that there was an increased risk of developing type 2 diabetes in the supplemented group.
Evidence from analysis of NHANES III [106] supports these findings; the adjusted mean se‐
rum selenium concentrations were slightly, but significantly, higher in diabetics compared
with those without the disease. This study, conducted in an elderly French population,
found a sex-specific protective effect of higher selenium status at baseline on later occur‐
rence of dysglycemia; that is, risk of dysglycemia was significantly lower in men with plas‐
ma selenium, but no significant relationship was observed in women [107].
The role of selenium as an antioxidant, particularly within the GPxs, selenium is likely to be
important in reducing oxidative stress, an important risk factor for developing diabetes.
There are also plausible suggestions that selenium can influence glucose metabolism. How‐
ever, at high intakes it is also conceivable that reactive oxygen species could be generated or
selenium may accumulate in the organs associated with glucose metabolism [108]. In pa‐
tients with diabetes, selenium supplementation (960 μg/day) reduced NF-κB levels to those
comparable with nondiabetic controls [109]. In addition, further analysis of the Nutritional
Prevention of Cancer trial data has shown an increased risk of self-reported Type-2 diabetes
in those supplemented with Se, though the effect was significant only in those in the top ter‐
tile of plasma Se at baseline [110].
2.10. Selenium and male fertility
Selenoprotein P transports selenium particularly to testis and brain [111]. Among the five
enzymes of GPx, GPx1 prevents apoptosis induced by oxidative stress and GPx4 acts direct‐
ly on membrane phospholipid hydroperoxides and detoxifies them. Selenium as GPx, is
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present in spermatids and forms the structural part in the mid piece of mature spermatozoa.
Some well known effects of selenium deficiency include instability of the middle piece lead‐
ing to defective sperm motility [112], low reproductive ability and abnormal development of
spermatozoa [113]. Selenium is also required for testosterone synthesis and sequential de‐
velopment of flagella [114]. It can restore the physiological constitution of polyunsaturated
fatty acid in the cell membrane [115]. Testes are extremely resistant to Se depletion and have
high Se content. Recent studies have shown that sperm and testicular Se was unaffected by
the supplementation, suggesting that testes are protected from Se excess as well as from Se
deficiency [116].
2.11. Selenium in asthma
Se status is decreased in patients with asthma, as is activity of glutathione peroxidase in pla‐
telets and erythrocytes. There is an associated marked oxidant/antioxidant imbalance in the
blood of asthmatics, which reflects poor antioxidant status and enhanced inflammatory
mediated oxidative stress [117]. According to the University of Maryland Medical Center, a
2004 study of 24 asthmatics that were given selenium supplements for 14 weeks had signifi‐
cant improvement in their symptoms when compared to a control group given a placebo.
Although this is a small study done over a short amount of time, it's encouraging [118].
2.12. Selenium in cardiovascular disorders
Free radicals are toxic to the myocardium and can cause tissue damage that leads to exten‐
sive necrosis, myocytolysis and cellular edema [119]. Atherosclerotic plaque formation may
be a reflection of sub-optimal GPx4 activity in the prevention of LDL oxidation, with subse‐
quent uptake by endothelial cells and macrophages in arterial blood vessels [120]. Selenium
via GPx reduces phospholipids, hydro peroxides and cholestryl esters associated with lipo‐
proteins and may therefore, not only reduce the accumulation of oxidized LDL in arterial
wall but also reduce platelet aggregation and activation of monocyte and macrophages
[121]. Selenium owing to its antithrombotic effect on the interaction between platelets and
endothelial cells via GPx, also provides concrete evidence in the prevention of atherosclero‐
sis [122].
The study on acute myocardial infarction (AMI) patients, it was observed that selenium de‐
pendent GPx level decreases significantly in AMI patients and explained it as an imperative
consequent of GPx activity in annihilating oxygen toxicity by metabolizing H2O2 and inhibit‐
ing further free oxygen radical production in early phase of myocardial infarction [123].
2.13. Selenium in rheumatoid arthritis
Scientific research shows that people with rheumatoid arthritis have low levels of selenium.
A study suggests, it is part of the body's defense mechanism [124]. In reference [125] the au‐
thors found lower selenium levels in patients with rheumatoid arthritis who were treated
with arthritis medication compared with people without the condition. In people without
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rheumatoid arthritis or a family history of the condition, low levels of the mineral may in‐
crease the risk of developing rheumatoid arthritis [126].
2.14. Selenium in pre-eclampsia
In reference [124], pre-eclampsia (pregnancy induced hypertension; PIH), is an important
cause of maternal morbidity and mortality with essentially unknown etiology. However, the
precise factors involved in the pathogenesis of PIH are still unknown [127]. It has been con‐
ceived that free radical mediated oxidative stress may contribute to the development of pre-
eclampsia. Selenium and its related enzymes especially GPx play a crucial role in
annihilating oxygen toxicity and there by controlling the progression of disease [128]. In ad‐
dition, selenium deficiency in women may result in infertility, miscarriages and retention of
the placenta [129].
2.15. Selenium in immunity
In reference [130], the generation of ROS in a limited dose is one of the processes induced by
the immune system to destroy microbial pathogens and viruses. However, the over-produc‐
tion of ROS can also cause damage to the host cells that need to be protected by Se at various
stages in the immune system. Keshan disease, an endemic cardiomyopathy in China that de‐
velops as a result of Se deficiency, may also be complicated with viral infection, and this has
led to the investigation of the effects of viruses, such as coxsackievirus, on Se-deficient ani‐
mals [131,132]. Results from animal studies have demonstrated that Se deficiency can lead to
an impairment of immune functions that result in the inability of phagocytic neutrophils
and macrophages to destroy antigens. A low Se status in humans has been reported to cause
a decreased immune response to poliovirus vaccination [133]. This study also demonstrated
that the subjects supplemented with Se showed fewer mutations in poliovirus than those
who received a placebo. The involvement of Se in the immune system may be associated
with a number of mechanisms, including the increased activity of natural killer (NK) cells,
the proliferation of T-lymphocytes, increased production of interferon c, increased high-af‐
finity interleukin-2 receptors, stimulation of vaccine-induced immunity and increased anti‐
body-producing B-cell numbers [134,135].
2.16. Selenium in bone impairments
Osteoblasts (bone-forming cells) and osteoclasts (bone-resorption cells) are involved in bone
remodeling. Therefore, any loss of osteoblastic activity or an increase in osteoclastic activity
could lead to a decrease in bone-mineral densities (BMD), bone mass, and make the bones
more likely to osteoporosis, and ultimately to fractures [136]. In addition, high levels of reac‐
tive oxygen species (ROS) and many other factors such as genetic race, hormonal, mechani‐
cal, and nutritional statues are involved in bone weakness and fractures. ROS shift cells into
a state of oxidative stress [137] which contributes to the etiology of various degenerative dis‐
eases that cause tissue injury [136,137]. Studies have demonstrated that the ischemia-reper‐
fusion processes that occur after a fracture are associated with oxidative stress development
[136,138]. It is believed that bone markers such as osteocalcin and alkaline phosphatase as
Oxidative Stress and Chronic Degenerative Diseases - A Role for Antioxidants430
well as antioxidant enzymes play a significant role in fracture healing. However, to the best
of our knowledge, there are no reports about the use of vitamins A, C, E, and selenium as
antioxidant therapy to explore their effects in the levels of bone-healing markers and oxida‐
tive stress parameters of osteoporotic patients. In [139] suggests that selenium is an impor‐
tant protective element that may be used as a dietary supplement protecting against bone
impairments.
3. Vitamin E and Health
3.1. Vitamin E
All forms of vitamin E meet the chemical definition of an antioxidant moiety: ‘‘chain-break‐
ing free radical scavenger.’’ Indeed consistent data have shown that all isoforms act as po‐
tent antioxidants in conventional in vitro paradigms. The free hydroxyl group on the
aromatic ring is thought to be responsible for this property, and a relatively stable form of
the original vitamin E is formed when hydrogen from this group is donated to a free radical.
Yet, definitive proof that vitamin E possesses antioxidant properties has been hampered for
a long time because of a lack of sensitive and specific analytical techniques to measure this
biologic event in vivo [36]. Apart from antioxidant properties, more recent studies have
clearly demonstrated that vitamin E also possesses important non-antioxidant cellular and
molecular functions. One of the first roles of α-tocopherol in cell signaling was the report
that it inhibits smooth muscle cell proliferation, decrease protein kinase C activity, and con‐
trols expression of the α-tropomyosin gene [140].
One of the major vitamin E-deficiency symptoms are neurological disorders. Furthermore,
vitamin E deficiency is related to female infertility. The frame to pinpoint the physiological
action of vitamin E is set by its chemical nature: (i) It is a redox-active compound prone to
undergo 1- and 2-electron transitions and (ii) it is highly lipophilic, although this property
may be modulated by phosphorylation [141]. In [142] oxidative stress is a developing re‐
search field and is being examined in female infertility. Prooxidants, also called free radicals
or reactive oxygen species (ROS), and their neutralizing agents the antioxidants are the main
chemicals of the oxidation mechanism. The term oxidative stress refers to the dysequilibri‐
um between the free radicals and the antioxidants in favor of the free radicals. In actuality,
free radicals are not so frightening, since they are necessary for the adequate reproductive
functions within the ovary and the endometrium. Vit E administration may improve the en‐
dometrial response in unexplained infertile women via the likely antioxidant and the antico‐
agulant effects. It may also modulate the antiestrogenic effect of clomiphene citrate and the
problem of a thin endometrium in these cycles may be adjusted.
Some non-antioxidant properties of vitamin E could play a key role in neuroprotection. It
has been recently shown that α-tocotrienol, at nanomolar concentrations, protects mouse
hippocampal and cortical neurons from cell death by modulating neurodegenerative signal‐
ing cascades. Furthermore, it has been shown that α-tocotrienol modulates 12-lipoxygenase
and phospholipase A2 activities, which are implicated in glutamate-induced neuronal cell
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death [143]. Some vitamin E forms (α- and γ-tocopherol, tocotrienols) also exhibit potent an‐
ti-inflammatory properties [144,145]. The introduction of the free radical theory of brain ag‐
ing has propelled a renewed interest in this vitamin. As result, by preventing and/or
minimizing the oxidative stress dependent brain damage, this vitamin plays important role
in brain aging, cognition, and Alzheimer’s dementia.
Vitamin E is a potent peroxyl radical scavenger that prevents lipid peroxidation [146] and is
found in high concentrations in immune cells [147]. Deficiency in vitamin E is associated
with increased oxidative stress [148] and impaired immune function, including both humor‐
al and cell-mediated immunity, phagocyte function, and lymphocyte proliferation [149].
Age-related declines in immune function can be restored by vitamin E supplementation
[150]. This vitamin is an exogenous, lipidsoluble antioxidant molecule. It is thought to be a
direct free radical scavenger by activating the intracellular antioxidant enzymes and saving
the cell membranes from lipid peroxidation, which was demonstrated on sperm membrane
components [151]. Its antioxidant effect was concluded in cancer therapy, high-risk pregnan‐
cy and male infertility [152-154].
Vitamin E (α−tocopherol acetate) is found within the phospholipid bilayer of cell mem‐
branes where it functions as an electron donor to free radicals. It has been recognized as one
of the body’s major natural antioxidants. Another antioxidant, Se appears to function as an
antimutagenic agent, preventing the malignant transformation of normal cells. Its protective
effects seem to be primarily associated with its presence in the seleno-enzymes which are
known to protect DNA and other cellular components from oxidative damage [44].
Selenium, vitamin A (retinol) and vitamin E (α-tocopherol) are essential micronutrients for
human health. Both selenium and vitamin E are important in host antioxidant defense and
immune function. It has been reported that deficiency of selenium and vitamins may pro‐
mote peroxidation events leading to the release of free radicals. All have free-radical-scav‐
enging properties that allow them to function as physiologic antioxidants in protecting a
number of chronic diseases, such as cancer and cardiovascular disease. In addition to its an‐
tioxidant capacity, α-tocopherol regulates expression of genes involved in a wide range of
cell functions, including cell cycle regulation, inflammation and cell adhesion, cell signaling,
and lipid uptake [155].
Selenium also has an important role in antioxidant defense and immune function. Due to its
incorporation as selenocysteine into glutathione peroxidase (GPX) [156] and thioredoxin re‐
ductase [157], selenium is important for the control of oxidative stress and, therefore, the re‐
dox tone of the cell. In total, there are 25 identified selenoproteins (24 in rodents), many with
unknown function [25]. Selenium is important for cytotoxic T-lymphocyte and natural killer
cell activity [158], respiratory burst [159], and protection against endotoxin-induced oxida‐
tive stress [160]. Multiple studies have shown that NF-kB activation can be affected by sele‐
nium status [161,162], and selenium deficiency can alter chemokine and cytokine expression
during viral infections [163]. Various investigators have reported the role of selenium as an
inhibitor of carcinogenesis in various organs including liver, skin, stomach, mammary
gland, gastrointestinal and oral cavity [164,165].
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In [166] blader cancer represents an important cause of morbidity and mortality. In 2010 it
was again the second most common genitourinary cancer in the United States with an estab‐
lished 70,530 new cases and 14,680 deaths [167]. Currently it is estimated that more than
500,000 men and women in the United States have a history of bladder cancer. The etiology
of most bladder urothelial carcinoma is associated with tobacco exposure, occupational ex‐
posure to aromatic amines, and exposure to the chemical and rubber industries [168]. Blad‐
der cancer is the most expensive cancer in the United States, accounting for almost $3.7
billion (2001 value) in direct costs [169]. There is substantial epidemiological and biological
evidence that selenium and vitamin E may prevent bladder cancer. A recent meta-analysis
of 7 published epidemiological studies, including 3 case-control, 3 nested case-control and 1
case cohort series, examined the association between selenium levels and bladder cancer
[170]. In the analysis stratified by gender only women showed a significantly decreased risk
associated with selenium. An opposite gender pattern, with protective effects in men but not
in women, was reported in a meta-analysis of selenium supplementation, primary cancer in‐
cidence and mortality [171]. Epidemiological and biological evidence suggests a preventive
effect of selenium and vitamin E on bladder cancer. These researches assessed the effect of
selenium and/or vitamin E on bladder cancer development.
3.2. Selenium and vitamin E
Selenium and vitamin E are essential components of the human diet and have been studied
as antioxidants and/or potential agents for a variety of human diseases. Various formula‐
tions of both selenium and vitamin E have been shown to possess a therapeutic and preven‐
tive effect against prostate cancer. The Selenium and Vitamin E Cancer prevention Trial
(SELECT) started in 2001 and was a phase III, randomized placebo/controlled human trial to
investigate the prostate cancer chemopreventive effects of selenium and vitamin E or their
combination [172,173].
Sselenium an essential trace element, and vitamin E, a lipid soluble antioxidant, are impor‐
tant mediators for protection against oxidative stress. Deficiencies in either Se or vitamin E
result in increased viral pathogenicity and altered immune responses. Furthermore, defi‐
ciencies in either Se or vitamin E results in specific viral mutations, changing relatively be‐
nign viruses into virulent ones. Thus, host nutritional status should be considered a driving
force for the emergence of new viral strains or newly pathogenic strains of known viruses
[174].
Several studies have evaluated the possible association between antioxidants vitamins or se‐
lenium supplement and the risk of prostate cancer, but the evidence is still inconsistent. We
systematically searched PubMed, EMBASE, the Cochrane Library, Science Citation Index
Expanded, Chinese biomedicine literature database, and bibliographies of retrieved articles
up to January 2009. We included 9 randomized controlled trials with 165,056 participants;
methodological quality of included trials was generally high. Meta-analysis showed that no
significant effects of supplementation with β-carotene (3 trials), vitamin C (2 trials), vitamin
E (5 trials), and selenium (2 trials)versus placebo on prostate cancer incidence. The mortality
of prostate cancer did not differ significantly by supplement of β-carotene (1 trial), vitamin
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C (1 trial), vitamin E (2 trials), and selenium (1 trial). This study indicates that antioxidant
vitamins and selenium supplement did not reduce the incidence and mortality of prostate
cancer; these data provide no support for the use of these supplements for the prevention of
prostate cancer [175].
Epidemiological studies demonstrated that human exposure to methylmercury (MeHg) may
contribute to the development and progression of metabolic and cardiovascular disorders.
However, the mechanisms involved and the role of selenium (Se) and vitamin E (VE) sup‐
plementation in modulating MeHg cardiovascular toxicities remain unclear. The effects of
Se and VE supplementation on MeHg-mediated systemic oxidative stress, antioxidant de‐
fense, inflammation, and endothelial dysfunction are carried out in an animal model. Male
Sprague–Dawley rats were fed a starch-based casein diet or the same diet supplemented
with 1 or 3 mg Se/kg diet and with or without 250 or 750 mg VE/kg diet. After 28 days of
dietary treatment, rats were gavaged with 0 or 3 mg MeHg/kg BW for 14 consecutive days.
Results suggested that exposure to MeHg may increase the risk of cardiovascular disease by
decreasing circulating paraoxonase-1 activities, increasing serum oxidized low density lipo‐
protein levels, and associated systemic inflammation and endothelial dysfunction as reflect‐
ed by increased leukocyte counts and serum levels of intercellular adhesion molecule-1 and
monocyte chemotactic protein-1. Se and VE supplementation may either alleviate or aug‐
ment the effects of MeHg, depending on their doses and combinations [176].
The analysis of the hepatotoxic effect of malathion in adult male rats and evaluate the possi‐
ble hepatoprotective effect of vitamin E and/or selenium. Oral administration of malathion
for 45 days significantly induced marked hepatic injury as revealed by increased activity of
the plasma enzymes (alanine aminotransferase (ALT), aspartate aminotransferase (AST), lac‐
tate dehydrogenase (LDH) and gamma-glutamyl transferase GGT). Oral administration of
vitamin E and selenium in combination with malathion exhibited a significant protective ef‐
fect by lowering the elevated plasma levels of the previous enzymes. Light microscopic in‐
vestigation revealed that malathion exposure was associated with necrosis of hepatocytes,
marked changes of liver tissues in the form of dilated veins, hemorrhagic spots and some
degenerative signs of hepatocytes [177].
4. Conclusion
Research on Se during the last few years has produced a great deal of evidence demonstrat‐
ing the important role that Se and its metabolites play in human diseases. In particular, our
knowledge of the functional roles of the GPx and TrxR groups as essential antioxidant sele‐
noenzymes in protecting cells from oxidative stress has greatly increased, as has the link be‐
tween these enzymes and various diseases. However, there are still areas of research that
require in-depth study, including the mechanistic modes of action of Se in cancer etiology,
how Se delivers its anticancer activity at the molecular and genetic levels, and what bio‐
markers can be used to accurately measure the efficacy of Se for use in chemoprevention. It
is not well understood the specific mechanism by which Se protects cells and tissue at the
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cellular level from damage due to oxidative stress; this is particularly relevant in heart dis‐
eases, which are still a major cause of death worldwide. Given the number of Se cancer pre‐
ventive trials that are currently being undertaken in many countries, the significant
outcomes of these trials will not only provide us with more information on optimal Se in‐
take for the treatment and prevention of cancer, but they will also provide us with strategies
in the management of other potential human diseases associated with low Se status. Until
the specific biomarkers are identified that will directly link Se with disease prevention and
treatment, its use as supplements in health therapy should be taken with caution.
The Selenium and Vitamin E Cancer prevention Trial (SELECT) failed to show an effect in
human population. However, pre- and pro-SELECT studies are still supporting the potential
usefulness of selenium and/or vitamin E for prevention of prostate cancer and possibly oth‐
er conditions. Much remains to be understood about the absorption, metabolism and phys‐
iologic chemistry of these agents. Nonetheless, the existing evidence supporting selenium
and vitamin E as potential prostate cancer chemopreventive agents is possibly enough to
justify further efforts in this direction.
My goal in putting this review together was to provide a wide range of subjects dealing
with selenium and vitamin E supplementation, that are used in chronic disease prevention,
due to their antiradical activities indicating that the combine effects of Se and vitamin E
could provide an important dietary source of antioxidants and/or potential agents for a vari‐
ety of human diseases. It is my hope that readers will find this chapter to be useful in further
studies dealing with this subject.
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